Deadline: June 15, 2009
Brain Tumor Funders' Collaborative Announces New Funding Opportunity
The eight North American private funding organizations comprising the Brain Tumor Funders' Collaborative have announced a new initiative aimed at accelerating development of non- or minimally-invasive methods for monitoring if, when, and how human brain tumors respond to investigational therapies.
BTFC's primary goal is bridging the "translational gap" that can prevent promising laboratory findings from yielding new medical treatments.
BTFC will provide up to ten one-year grants of up to $100,000 to facilitate projects working to design, develop, test, and validate non- or minimally-invasive response markers. Following review of each funded project's progress, the BTFC may provide additional support as warranted to projects demonstrating the greatest likelihood of continued success in bringing new tools into widespread use.
BTFC anticipates that proposals submitted in response to this RFP may comprise a broad span across the research spectrum. The program is willing to consider promising but as of yet completely novel and untested approaches as well as proposals requesting funding for more developed approaches requiring final feasibility testing, or validation in brain tumor patients, or demonstrations of generalizability across sites.
Proposals can be initiated by either researchers or clinicians. Grant contracts will be negotiated with a single U.S.-based 501(c)(3) institution or equivalent Canadian institution identified as the sponsoring institution.
Complete program details are available at the Brain Tumor Funders Web site.
Link to Complete RFP